Constellation Brands, Lindsay Corporation, Anheuser Busch Inbev SA Sponsor, Bristol Myers Squibb Company, Merck Company, Astrazeneca PLC, Philip Morris International, and British American Tobacco Indus" name="Description" /> Constellation Brands, Lindsay Corporation, Anheuser Busch Inbev SA Sponsor, Bristol Myers Squibb Company, Merck Company, Astrazeneca PLC, Philip Morris International, and British American Tobacco Indus" /> Constellation Brands, Lindsay Corporation, Anheuser Busch Inbev SA Sponsor, Bristol Myers Squibb Company, Merck Company, Astrazeneca PLC, Philip Morris International, and British American Tobacco Indus" />

The Top 8 Compulsion stocks to own in September 2019

Today I will concentrate on 8 Compulsion isntruments to have in your portfolio in September 2019. I will cover Constellation Brands, Lindsay Corporation, Anheuser Busch Inbev SA Sponsor, Bristol Myers Squibb Company, Merck Company, Astrazeneca PLC, Philip Morris International, and British American Tobacco Indus
Published over a year ago
View all stories for Macroaxis | View All Stories
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.

Reviewed by Michael Smolkin

This list of potential positions covers Addiction driven consumer products and services. Companies involved in research, development, and manufacturing of products with compulsion characteristics such as cigarettes, addictive drugs and alcohol in USA. Please note, we provide buy hold or sell recommendation only in the context of selected investment horizon assuming investor has average attitude towards taking risk. Please also consider using Portfolio Positions Ratings and Equity Ratings tools to further calibrate your research.
Story appears to be empty

Constellation Brands Class (STZ)

The company has Return on Asset of 0.0803 % which means that on every $100 spent on assets, it made $0.0803 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1878 %, implying that it generated $0.1878 on every 100 dollars invested. Constellation Brands' management efficiency ratios could be used to measure how well Constellation Brands manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.02 in 2024. Return On Capital Employed is likely to drop to 0.06 in 2024. At this time, Constellation Brands' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 23.1 B in 2024, whereas Total Current Assets are likely to drop slightly above 2 B in 2024. This firm currently falls under 'Large-Cap' category with a total capitalization of 47.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Constellation Brands's market, we take the total number of its shares issued and multiply it by Constellation Brands's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Constellation Brands shows a prevailing Real Value of $275.44 per share. The current price of the firm is $258.68. Our model approximates the value of Constellation Brands from analyzing the firm fundamentals such as Return On Equity of 0.19, current valuation of 59.2 B, and Profit Margin of 0.17 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Lindsay (LNN)

The company has Return on Asset of 0.0789 % which means that on every $100 spent on assets, it made $0.0789 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.153 %, implying that it generated $0.153 on every 100 dollars invested. Lindsay's management efficiency ratios could be used to measure how well Lindsay manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Lindsay's Return On Capital Employed is very stable compared to the past year. As of the 19th of April 2024, Return On Assets is likely to grow to 0.11, while Return On Tangible Assets are likely to drop 0.12. At this time, Lindsay's Return On Assets are very stable compared to the past year. As of the 19th of April 2024, Asset Turnover is likely to grow to 1.53, while Non Currrent Assets Other are likely to drop about 15.4 M. This firm currently falls under 'Mid-Cap' category with a total capitalization of 1.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lindsay's market, we take the total number of its shares issued and multiply it by Lindsay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

164.35 Million

At this time, Lindsay's Short and Long Term Debt Total is very stable compared to the past year.

Anheuser Busch Inbev (BUD)

The company has Return on Asset of 0.0416 % which means that on every $100 spent on assets, it made $0.0416 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0779 %, implying that it generated $0.0779 on every 100 dollars invested. Anheuser Busch's management efficiency ratios could be used to measure how well Anheuser Busch manages its routine affairs as well as how well it operates its assets and liabilities. At present, Anheuser Busch's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. At present, Anheuser Busch's Asset Turnover is projected to slightly decrease based on the last few years of reporting. This firm currently falls under 'Mega-Cap' category with a total capitalization of 113.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anheuser Busch's market, we take the total number of its shares issued and multiply it by Anheuser Busch's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Anheuser Busch Inbev shows a prevailing Real Value of $63.13 per share. The current price of the firm is $57.91. Our model approximates the value of Anheuser Busch Inbev from analyzing the firm fundamentals such as return on equity of 0.0779, and Profit Margin of 0.09 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Bristol Myers Squibb (BMY)

The company has Return on Asset of 0.0563 % which means that on every $100 spent on assets, it made $0.0563 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2653 %, implying that it generated $0.2653 on every 100 dollars invested. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bristol Myers' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.14 in 2024, whereas Return On Tangible Assets are likely to drop 0.15 in 2024. At this time, Bristol Myers' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 66.6 B in 2024, whereas Other Assets are likely to drop slightly above 3.3 B in 2024. The entity currently falls under 'Large-Cap' category with a total capitalization of 97.89 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

43.54 Billion

At this time, Bristol Myers' Short and Long Term Debt Total is fairly stable compared to the past year.

Merck Company (MRK)

The company has Return on Asset of 0.0264 % which means that on every $100 spent on assets, it made $0.0264 of profit. This is way below average. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.01. The value of Return On Capital Employed is expected to slide to 0.04. At this time, Merck's Non Current Liabilities Total is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 10.8 B this year, although the value of Total Current Liabilities will most likely fall to about 13.3 B. The entity currently falls under 'Mega-Cap' category with a total capitalization of 316.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Merck Company secures a last-minute Real Value of $121.16 per share. The latest price of the firm is $125.23. Our model forecasts the value of Merck Company from analyzing the firm fundamentals such as Current Valuation of 345.96 B, profit margin of 0.01 %, and Return On Equity of 0.009 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

AstraZeneca PLC ADR (AZN)

The company has Return on Asset of 0.066 % which means that on every $100 spent on assets, it made $0.066 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1564 %, implying that it generated $0.1564 on every 100 dollars invested. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Assets is likely to grow to 0.10, while Return On Tangible Assets are likely to drop 0.11. At this time, AstraZeneca PLC's Tangible Asset Value is very stable compared to the past year. As of the 19th of April 2024, Intangibles To Total Assets is likely to grow to 0.60, while Total Current Assets are likely to drop about 15.3 B. The entity currently falls under 'Mega-Cap' category with a total capitalization of 211.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

30.05 Billion

At this time, AstraZeneca PLC's Short and Long Term Debt Total is very stable compared to the past year.

Philip Morris International (PM)

The company has Return on Asset (ROA) of 0.125 % which means that for every $100 of assets, it generated a profit of $0.125. This is way below average. Philip Morris' management efficiency ratios could be used to measure how well Philip Morris manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Philip Morris' Return On Tangible Assets are very stable compared to the past year. As of the 19th of April 2024, Return On Capital Employed is likely to grow to 0.38, though Return On Equity is likely to grow to (0.66). At this time, Philip Morris' Asset Turnover is very stable compared to the past year. The entity currently falls under 'Mega-Cap' category with a market capitalization of 141.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Philip Morris's market, we take the total number of its shares issued and multiply it by Philip Morris's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be undervalued. Philip Morris Intern holds a recent Real Value of $101.27 per share. The prevailing price of the company is $91.2. Our model determines the value of Philip Morris Intern from analyzing the company fundamentals such as Return On Asset of 0.13, shares owned by insiders of 0.15 %, and Current Valuation of 188.96 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

British American Tobacco (BTI)

The company has Return on Asset of 0.058 % which means that on every $100 spent on assets, it made $0.058 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2206) %, meaning that it generated no profit with money invested by stockholders. British Amer's management efficiency ratios could be used to measure how well British Amer manages its routine affairs as well as how well it operates its assets and liabilities. The British Amer's current Return On Tangible Assets is estimated to increase to -0.59. The British Amer's current Return On Capital Employed is estimated to increase to -0.15. As of now, British Amer's Intangible Assets are increasing as compared to previous years. The British Amer's current Intangibles To Total Assets is estimated to increase to 0.85, while Other Current Assets are projected to decrease to under 185.2 M. This firm currently falls under 'Large-Cap' category with a total capitalization of 63.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate British Amer's market, we take the total number of its shares issued and multiply it by British Amer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

41.72 Billion

As of now, British Amer's Short and Long Term Debt Total is increasing as compared to previous years.

Current Compulsion Recommendations


How important is Macroaxis's Liquidity

Macroaxis financial leverage refers to using borrowed capital as a funding source to finance Macroaxis ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Macroaxis financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Macroaxis' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Macroaxis' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Macroaxis's total debt and its cash.

Macroaxis Gross Profit

Macroaxis Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Macroaxis previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Macroaxis Gross Profit growth over the last 10 years. Please check Macroaxis' gross profit and other fundamental indicators for more details.
Story appears to be empty

Constellation Brands Class (STZ)

The company has Return on Asset of 0.0803 % which means that on every $100 spent on assets, it made $0.0803 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1878 %, implying that it generated $0.1878 on every 100 dollars invested. Constellation Brands' management efficiency ratios could be used to measure how well Constellation Brands manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.02 in 2024. Return On Capital Employed is likely to drop to 0.06 in 2024. At this time, Constellation Brands' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 23.1 B in 2024, whereas Total Current Assets are likely to drop slightly above 2 B in 2024. This firm currently falls under 'Large-Cap' category with a total capitalization of 47.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Constellation Brands's market, we take the total number of its shares issued and multiply it by Constellation Brands's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Constellation Brands shows a prevailing Real Value of $275.44 per share. The current price of the firm is $258.68. Our model approximates the value of Constellation Brands from analyzing the firm fundamentals such as Return On Equity of 0.19, current valuation of 59.2 B, and Profit Margin of 0.17 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor acquiring undervalued instruments and dropping overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Lindsay (LNN)

The company has Return on Asset of 0.0789 % which means that on every $100 spent on assets, it made $0.0789 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.153 %, implying that it generated $0.153 on every 100 dollars invested. Lindsay's management efficiency ratios could be used to measure how well Lindsay manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Lindsay's Return On Capital Employed is very stable compared to the past year. As of the 19th of April 2024, Return On Assets is likely to grow to 0.11, while Return On Tangible Assets are likely to drop 0.12. At this time, Lindsay's Return On Assets are very stable compared to the past year. As of the 19th of April 2024, Asset Turnover is likely to grow to 1.53, while Non Currrent Assets Other are likely to drop about 15.4 M. This firm currently falls under 'Mid-Cap' category with a total capitalization of 1.29 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lindsay's market, we take the total number of its shares issued and multiply it by Lindsay's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

164.35 Million

At this time, Lindsay's Short and Long Term Debt Total is very stable compared to the past year.

Anheuser Busch Inbev (BUD)

The company has Return on Asset of 0.0416 % which means that on every $100 spent on assets, it made $0.0416 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0779 %, implying that it generated $0.0779 on every 100 dollars invested. Anheuser Busch's management efficiency ratios could be used to measure how well Anheuser Busch manages its routine affairs as well as how well it operates its assets and liabilities. At present, Anheuser Busch's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. At present, Anheuser Busch's Asset Turnover is projected to slightly decrease based on the last few years of reporting. This firm currently falls under 'Mega-Cap' category with a total capitalization of 113.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anheuser Busch's market, we take the total number of its shares issued and multiply it by Anheuser Busch's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be undervalued. Anheuser Busch Inbev shows a prevailing Real Value of $63.13 per share. The current price of the firm is $57.91. Our model approximates the value of Anheuser Busch Inbev from analyzing the firm fundamentals such as return on equity of 0.0779, and Profit Margin of 0.09 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Bristol Myers Squibb (BMY)

The company has Return on Asset of 0.0563 % which means that on every $100 spent on assets, it made $0.0563 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2653 %, implying that it generated $0.2653 on every 100 dollars invested. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bristol Myers' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.14 in 2024, whereas Return On Tangible Assets are likely to drop 0.15 in 2024. At this time, Bristol Myers' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 66.6 B in 2024, whereas Other Assets are likely to drop slightly above 3.3 B in 2024. The entity currently falls under 'Large-Cap' category with a total capitalization of 97.89 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

43.54 Billion

At this time, Bristol Myers' Short and Long Term Debt Total is fairly stable compared to the past year.

Merck Company (MRK)

The company has Return on Asset of 0.0264 % which means that on every $100 spent on assets, it made $0.0264 of profit. This is way below average. Merck's management efficiency ratios could be used to measure how well Merck manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.01. The value of Return On Capital Employed is expected to slide to 0.04. At this time, Merck's Non Current Liabilities Total is quite stable compared to the past year. Non Current Liabilities Other is expected to rise to about 10.8 B this year, although the value of Total Current Liabilities will most likely fall to about 13.3 B. The entity currently falls under 'Mega-Cap' category with a total capitalization of 316.78 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the firm appears to be fairly valued. Merck Company secures a last-minute Real Value of $121.16 per share. The latest price of the firm is $125.23. Our model forecasts the value of Merck Company from analyzing the firm fundamentals such as Current Valuation of 345.96 B, profit margin of 0.01 %, and Return On Equity of 0.009 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

AstraZeneca PLC ADR (AZN)

The company has Return on Asset of 0.066 % which means that on every $100 spent on assets, it made $0.066 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1564 %, implying that it generated $0.1564 on every 100 dollars invested. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Assets is likely to grow to 0.10, while Return On Tangible Assets are likely to drop 0.11. At this time, AstraZeneca PLC's Tangible Asset Value is very stable compared to the past year. As of the 19th of April 2024, Intangibles To Total Assets is likely to grow to 0.60, while Total Current Assets are likely to drop about 15.3 B. The entity currently falls under 'Mega-Cap' category with a total capitalization of 211.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

30.05 Billion

At this time, AstraZeneca PLC's Short and Long Term Debt Total is very stable compared to the past year.

Philip Morris International (PM)

The company has Return on Asset (ROA) of 0.125 % which means that for every $100 of assets, it generated a profit of $0.125. This is way below average. Philip Morris' management efficiency ratios could be used to measure how well Philip Morris manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Philip Morris' Return On Tangible Assets are very stable compared to the past year. As of the 19th of April 2024, Return On Capital Employed is likely to grow to 0.38, though Return On Equity is likely to grow to (0.66). At this time, Philip Morris' Asset Turnover is very stable compared to the past year. The entity currently falls under 'Mega-Cap' category with a market capitalization of 141.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Philip Morris's market, we take the total number of its shares issued and multiply it by Philip Morris's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. At this time, the company appears to be undervalued. Philip Morris Intern holds a recent Real Value of $101.27 per share. The prevailing price of the company is $91.2. Our model determines the value of Philip Morris Intern from analyzing the company fundamentals such as Return On Asset of 0.13, shares owned by insiders of 0.15 %, and Current Valuation of 188.96 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together.

British American Tobacco (BTI)

The company has Return on Asset of 0.058 % which means that on every $100 spent on assets, it made $0.058 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2206) %, meaning that it generated no profit with money invested by stockholders. British Amer's management efficiency ratios could be used to measure how well British Amer manages its routine affairs as well as how well it operates its assets and liabilities. The British Amer's current Return On Tangible Assets is estimated to increase to -0.59. The British Amer's current Return On Capital Employed is estimated to increase to -0.15. As of now, British Amer's Intangible Assets are increasing as compared to previous years. The British Amer's current Intangibles To Total Assets is estimated to increase to 0.85, while Other Current Assets are projected to decrease to under 185.2 M. This firm currently falls under 'Large-Cap' category with a total capitalization of 63.59 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate British Amer's market, we take the total number of its shares issued and multiply it by British Amer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Short Long Term Debt Total

41.72 Billion

As of now, British Amer's Short and Long Term Debt Total is increasing as compared to previous years.

Current Compulsion Recommendations

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any private could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Consideration for investing

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios